Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity

Abstract

Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation.

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 03, 2023
Source ID
10.1038/s41467-023-36106-x

Entities

People

  • Adelola B. Ajayi
  • Agnes Hajduczki
  • Benjamin J Doranz
  • Caitlin Kuklis
  • Caroline E. Peterson
  • Christopher C Broder
  • Courtney Corbitt
  • Debora Duso
  • Dominic Paquin Proulx
  • Edgar Davidson
  • Elizabeth J. Martinez
  • Emily S. Golub
  • Eric D. Laing
  • Eric Lewitus
  • Gregory D. Gromowski
  • Hanover Matz
  • Helen Dooley
  • Hongjun Bai
  • Isabella Swafford
  • Jazmean K. Williams
  • Jocelyn King
  • Kayvon Modjarrad
  • Larry Kummer
  • Layla Dawit
  • Lianying Yan
  • Lindsay Wieczorek
  • M Gordon Joyce
  • Michelle Zemil
  • Misook Choe
  • Morgane Rolland
  • Paul V. Thomas
  • Phyllis A. Rees
  • Rajeshwer S. Sankhala
  • Sandra V. Mayer
  • Sandrine Soman
  • Sapna David
  • Shelly J. Krebs
  • Spencer L. Sterling
  • Thomas M. Hill
  • Tricia Hart
  • Victoria R. Polonis
  • Vincent Dussupt
  • Wei‐Hung Chen
  • William C Chang
  • William W. Reiley

Organizations

  • Defense Health Agency

Tags

Fields of Study

  • Biology

Readers

  • Infectious Disease/Epidemiology
  • Molecular and Cellular Biochemistry
  • Oncology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech